Zuhao Li

Zuhao Li

Auto-generated profile, based on publicly available information

Zuhao Li

Orthopaedic Medical Center, The Second Hospital of Jilin University, Orthopaedic Research Institute of Jilin Province, Changchun, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 November 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
YZYue Zhao
Yue Zhao
SSShanliang Song
Shanliang Song
Dongdong WangDongdong Wang
Dongdong Wang
HLHe Liu
He Liu
JZJunmin Zhang
Junmin Zhang
YZYanli Zhao
Yanli Zhao
Stem cell-based therapy has drawn attention for enhancing the osseointegration efficiency after joint replacement in the rheumatoid arthritis (RA). However, therapeutic efficacy of this approach is threatened by the accumulated reactive oxygen species (ROS) and poor oxygen supply. Herein, we develop a nanozyme-reinforced hydrogel for reshaping the hostile RA microenvironment and improving prosthetic interface osseointegration. The engineered hydrogel not only scavenges endogenously over-expressed ROS, but also synergistically produces dissolved oxygen. Such performance enables the hydrogel to be utilized as an injectable delivery vehicle of bone marrow-derived mesenchymal stem cells (BMSCs) to protect implanted cells from ROS and hypoxia-mediated death and osteogenic limitation. This nanozyme-reinforced hydrogel encapsulated with BMSCs can alleviate the symptoms of RA, including suppression of local inflammatory cytokines and improvement of osseointegration. This work provides a strategy for solving the long-lasting challenge of stem cell transplantation and revolutionizes conventional intervention methods for improving prosthetic interface osseointegration in RA.

9 October 2022 in Advanced Healthcare Materials
Verified
Journal Article
Closed access
ZLZuhao Li
Zuhao Li
YZYue Zhao
Yue Zhao
HHHanwei Huang
Hanwei Huang
CZChangru Zhang
Changru Zhang
HLHe Liu
He Liu
JWJinwu Wang
Jinwu Wang

1 January 2020 in Journal of Tissue Engineering
Verified
Journal Article
Open access
PDF file
HBHaotian Bai
Haotian Bai
NKNoh Kyu-Cheol
Noh Kyu-Cheol
ZWZhonghan Wang
Zhonghan Wang
YCYutao Cui
Yutao Cui
HLHe Liu
He Liu
ZLZuhao Li
Zuhao Li
A diabetic foot ulcer (DFUs) is a state of prolonged chronic inflammation, which can result in amputation. Different from normal skin wounds, various commercially available dressings have not sufficiently improved the healing of DFUs. In this study, a novel self-healing hydrogel was prepared by in situ crosslinking of N-carboxyethyl chitosan (N-chitosan) and adipic acid dihydrazide (ADH) with hyaluronic acid-aldehyde (HA-ALD), to provide a moist and inflammatory relief environment to promote stem cell proliferation or secretion of growth factors, thus accelerating wound healing. The results demonstrated that this injectable and self-healing hydrogel has excellent swelling properties, stability, and mechanical properties. This biocompatible hydrogel stimulated secretion of growth factors from bone marrow mesenchymal stem cells (BM-MSCs) and regulated the inflammatory environment by inhibiting the expression of M1 macrophages and promoting the expression of M2 macrophages, resulting in granulation tissue formation, collagen deposition, nucleated cell proliferation, neovascularization, and enhanced diabetic wound healing. This study showed that N-chitosan/HA-ALD hydrogel could be used as a multifunctional injectable wound dressing to regulate chronic inflammation and provide an optimal environment for BM-MSCs to promote diabetic wound healing.

1 January 2020 in Journal of Tissue Engineering
Verified
Journal Article
Open access
PDF file
ZWZhonghan Wang
Zhonghan Wang
HLHe Liu
He Liu
WLWenbin Luo
Wenbin Luo
TCTianyang Cai
Tianyang Cai
ZLZuhao Li
Zuhao Li
XYXiaoyu Yang
Xiaoyu Yang
Natural biomaterials, such as collagen, gelatin, and chitosan, are considered as promising candidates for use in tissue regeneration treatment, given their similarity to natural tissues regarding components and structure. Nevertheless, only receiving a crosslinking process can these biomaterials exhibit sufficient strength to bear high tensile loads for use in skeletal system regeneration. Recently, genipin, a natural chemical compound extracted from gardenia fruits, has shown great potential as a reliable crosslinking reagent, which can reconcile the crosslinking effect and biosafety profile simultaneously. In this review, we briefly summarize the genipin extraction process, biosafety, and crosslinking mechanism. Subsequently, the applications of genipin regarding aiding skeletal system regeneration are discussed in detail, including the advances and technological strategies for reconstructing cartilage, bone, intervertebral disc, tendon, and skeletal muscle tissues. Finally, based on the specific pharmacological functions of genipin, its potential applications, such as its use in bioprinting and serving as an antioxidant and anti-tumor agent, and the challenges of genipin in the clinical applications in skeletal system regeneration are also presented.

1 January 2020 in Journal of Tissue Engineering
Verified
Journal Article
Open access
PDF file
SQShichong Qiao
Shichong Qiao
DWDongle Wu
Dongle Wu
ZLZuhao Li
Zuhao Li
YZYu Zhu
Yu Zhu
FZFei Zhan
Fei Zhan
YGYingxin Gu
Yingxin Gu
Biomaterial with the dual-functions of bone regeneration and antibacterial is a novel therapy for infective bone defects. Three-dimensional (3D)-printed porous titanium (pTi) benefits bone ingrowth, but its microporous structure conducive to bacteria reproduction. Herein, a multifunctional hydrogel was prepared from dynamic supramolecular assembly of sodium tetraborate (Na2B4O7), polyvinyl alcohol (PVA), silver nanoparticles (AgNPs) and tetraethyl orthosilicate (TEOS), and composited with pTi as an implant system. The pTi scaffolds have ideal pore size and porosity matching with bone, while the supramolecular hydrogel endows pTi scaffolds with antibacterial and biological activity. In vitro assessments indicated the 3D composite implant was biocompatible, promoted bone marrow mesenchymal stem cells (BMSCs) proliferation and osteogenic differentiation, and inhibited bacteria, simultaneously. In vivo experiments further demonstrated that the implant showed effective antibacterial ability while promoting bone regeneration. Besides distal femur defect, the innovative scaffolds may also serve as an ideal biomaterial (e.g. dental implants) for other contaminated defects.

17 January 2022 in Advanced Healthcare Materials
Verified
Journal Article
Closed access
PDF file
ZLZuhao Li
Zuhao Li
YZYue Zhao
Yue Zhao
ZWZhonghan Wang
Zhonghan Wang
MRMing Ren
Ming Ren
XWXiangang Wang
Xiangang Wang
JWJincheng Wang
Jincheng Wang